Health And Medicine
-
Investigational new drug for Alzheimer’s scheduled for first study in humans
Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center. Read MoreDec 27, 2016
-
Discovery sheds new light on Angelman, Prader-Willi syndromes
A mutation associated with epilepsy and autism also is responsible for a “pale eye” trait in two rare genetic disorders, Angelman syndrome and Prader-Willi syndrome, neuroscientists at Vanderbilt University Medical Center reported this week. Read MoreDec 22, 2016
-
New clues emerge in rare form of childhood epilepsy
Researchers at Vanderbilt University Medical Center (VUMC) are one step closer to understanding what causes early-onset epileptic encephalopathy, a rare form of childhood epilepsy that is difficult to treat and has poor developmental outcomes. Read MoreDec 15, 2016
-
Babies born with opioid withdrawal disproportionately increasing in rural areas
An increasing number of newborns are being born with drug withdrawal symptoms from opioids in rural areas of the United States as compared to births in urban areas, according to a JAMA Pediatrics study. Read MoreDec 15, 2016
-
Vanderbilt earns top rankings, including a No. 1, for successful minority recruitment in master’s and Ph.D. programs
"Diverse: Issues In Higher Education" has ranked Vanderbilt University No. 1 in the country for the number of doctoral degrees awarded to African Americans in the biological and biomedical sciences. Read MoreDec 12, 2016
-
Single-cell analysis of solid tumors
A new method will make it possible to study solid tumors and healthy tissues using mass cytometry. Read MoreDec 12, 2016
-
Protecting the blood-brain barrier
Vanderbilt investigators have discovered how a promising cancer immunotherapy causes brain swelling, findings that could lead to ways to protect brain function while fighting cancers. Read MoreDec 9, 2016
-
Making human beta cells reproduce
A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells. Read MoreDec 8, 2016
-
Plasmin prevents muscle ‘hardening’ after injury: study
Vanderbilt researchers have made the surprising discovery that the protease plasmin, known for its clot-busting role in the blood, protects soft tissue from turning to bone after severe injuries and certain orthopaedic surgeries. Read MoreDec 8, 2016
-
VUSN professor receives grant to study self-care for cancer survivors
School of Nursing Assistant Professor Jie Deng has been awarded a $789,000 research scholar grant by the American Cancer Society to develop and test a self-care program for head and neck cancer survivors diagnosed with secondary lymphedema and fibrosis. Read MoreDec 7, 2016
-
Basic Science Research Advisory Committee formed
Vanderbilt University School of Medicine (VUSM) has formed a new Basic Science Research Advisory Committee. Read MoreDec 1, 2016
-
Study tests shorter antibiotic course in children
Researchers at Vanderbilt University Medical Center (VUMC) are leading a multicenter clinical trial to evaluate whether a shorter course of antibiotics — five days instead of 10 — is effective at treating community-acquired pneumonia (CAP) in children who show improvement after the first few days of taking antibiotics. Read MoreDec 1, 2016
-
Rockefeller University’s Elaine Fuchs, Ph.D., named 2016 recipient of the Vanderbilt Prize in Biomedical Science
Elaine Fuchs, Ph.D., whose innovative use of reverse genetics has helped redefine the study of skin diseases and cancer stem cells, is the recipient of the 2016 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center (VUMC) announced today. Read MoreNov 28, 2016
-
Reducing antidepressants’ side effects
Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk. Read MoreNov 23, 2016
-
Building the basement membrane
Vanderbilt researchers have discovered steps in the regulation of a key enzyme that builds the basement membrane, a structure that undergirds nearly all animal tissues. Read MoreNov 21, 2016
-
Targeting the “un-targetable”
A novel drug that targets the protein RSK blocked aggressive breast cancers from metastasizing in an animal model. Read MoreNov 18, 2016
-
Graduate student’s cancer studies land NCI support
Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University. Read MoreNov 17, 2016
-
Stem cells promote tolerance
Blood-forming stem cells play a role in immune tolerance and acceptance of organ transplants, Vanderbilt researchers have discovered. Read MoreNov 17, 2016
-
Protein structure and epilepsy severity
Understanding how mutations affect the structure and function of inhibitory neurotransmitter receptors will shed light on the mechanisms underlying some types of epilepsy. Read MoreNov 10, 2016
-
Improving wound healing
Vanderbilt researchers have shown that an injectable material improves wound healing and may be useful for large skin wounds such as those in patients with diabetes. Read MoreNov 8, 2016